| Targeting the transferrin receptor for brain drug delivery KB Johnsen, A Burkhart, LB Thomsen, TL Andresen, T Moos Progress in neurobiology 181, 101665, 2019 | 281 | 2019 |
| Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma. KB Johnsen, A Burkhart, T Moos Scientific reports, 2007 | 258* | 2007 |
| A triple culture model of the blood-brain barrier using porcine brain endothelial cells, astrocytes and pericytes LB Thomsen, A Burkhart, T Moos PloS one 10 (8), e0134765, 2015 | 172 | 2015 |
| Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology T Skjørringe, A Burkhart, KB Johnsen, T Moos Frontiers in Molecular Neuroscience 8, 19, 2015 | 162 | 2015 |
| Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo KB Johnsen, M Bak, F Melander, MS Thomsen, A Burkhart, PJ Kempen, ... Journal of Controlled Release 295, 237-249, 2019 | 148 | 2019 |
| Antibody affinity and valency impact brain uptake of transferrin receptor-targeted gold nanoparticles KB Johnsen, M Bak, PJ Kempen, F Melander, A Burkhart, MS Thomsen, ... Theranostics 8 (12), 3416, 2018 | 133 | 2018 |
| Synthesis and deposition of basement membrane proteins by primary brain capillary endothelial cells in a murine model of the blood–brain barrier MS Thomsen, S Birkelund, A Burkhart, A Stensballe, T Moos Journal of neurochemistry 140 (5), 741-754, 2017 | 108 | 2017 |
| Expression of iron-related proteins at the neurovascular unit supports reduction and reoxidation of iron for transport through the blood-brain barrier A Burkhart, T Skjørringe, KB Johnsen, P Siupka, LB Thomsen, MS Nielsen, ... Molecular neurobiology 53, 7237-7253, 2016 | 95 | 2016 |
| The blood-brain barrier studied in vitro across species MS Thomsen, N Humle, E Hede, T Moos, A Burkhart, LB Thomsen PLoS One 16 (3), e0236770, 2021 | 57 | 2021 |
| Transfection of brain capillary endothelial cells in primary culture with defined blood–brain barrier properties A Burkhart, LB Thomsen, MS Thomsen, J Lichota, C Fazakas, I Krizbai, ... Fluids and Barriers of the CNS 12, 1-14, 2015 | 54 | 2015 |
| Transfection of primary brain capillary endothelial cells for protein synthesis and secretion of recombinant erythropoietin: a strategy to enable protein delivery to the brain A Burkhart, TL Andresen, A Aigner, LB Thomsen, T Moos Cellular and Molecular Life Sciences 74, 2467-2485, 2017 | 18 | 2017 |
| Gene therapy to the blood–brain barrier with resulting protein secretion as a strategy for treatment of Niemann Picks type C2 disease E Hede, CB Christiansen, CW Heegaard, T Moos, A Burkhart Journal of neurochemistry 156 (3), 290-308, 2021 | 17 | 2021 |
| Accessing targeted nanoparticles to the brain: The vascular route A Burkhart, M Azizi, MS Thomsen, LB Thomsen, T Moos Current medicinal chemistry 21 (36), 4092-4099, 2014 | 15 | 2014 |
| Sortilin regulates blood–brain barrier integrity AE Toth, HC Helms, A Harazin, KB Johnsen, C Goldeman, A Burkhart, ... The FEBS Journal 289 (4), 1062-1079, 2022 | 14 | 2022 |
| A novel strategy for delivering N iemann‐P ick type C2 proteins across the blood–brain barrier using the brain endothelial‐specific AAV‐BR1 virus CLM Rasmussen, E Hede, LJ Routhe, J Körbelin, SS Helgudottir, ... Journal of Neurochemistry 164 (1), 6-28, 2023 | 11 | 2023 |
| Epigenetic regulation of ferroportin in primary cultures of the rat blood-brain barrier SS Helgudottir, LJ Routhe, A Burkhart, K Jønsson, IS Pedersen, J Lichota, ... Molecular neurobiology 57, 3526-3539, 2020 | 11 | 2020 |
| Nanoparticle-derived non-viral genetic transfection at the blood-brain barrier to enable neuronal growth factor delivery by secretion from brain endothelium L B Thomsen, A B Larsen, J Lichota, T Moos Current medicinal chemistry 18 (22), 3330-3334, 2011 | 10 | 2011 |
| The cell-penetrating peptide tat facilitates effective internalization of PSD-95 inhibitors into blood–brain barrier endothelial cells but less efficient permeation across the … EL Al Humaidan, SL Pedersen, A Burkhart, CLM Rasmussen, T Moos, ... Frontiers in Drug Delivery 2, 854703, 2022 | 9 | 2022 |
| Hepcidin mediates transcriptional changes in ferroportin mRNA in differentiated neuronal-like PC12 cells subjected to iron challenge SS Helgudottir, J Lichota, A Burkhart, T Moos Molecular Neurobiology 56, 2362-2374, 2019 | 6 | 2019 |
| The blood-brain barrier in vitro using primary culture: implications for studies of therapeutic gene expression and iron transport AB Larsen River Publishers, 2014 | 5 | 2014 |
Torben MoosAalborg UniversityVerificeret mail på hst.aau.dk
